Перкарбонат натрия

Sodium percarbonate appears on labels as an "oxygen whitening" agent. It is one of the few peroxide compounds stable enough to survive in a dry formulation yet reactive enough to release active oxygen immediately upon contact with water or saliva.

What It Is

Sodium percarbonate is an adduct of sodium carbonate (Na₂CO₃) and hydrogen peroxide. The notation Na₂CO₃·1.5H₂O₂ indicates that H₂O₂ molecules are embedded in the crystal lattice of sodium carbonate through hydrogen bonding — not covalently bonded. CAS: 15630-89-4.

It appears as white granules or crystals and dissolves readily in water. Upon dissolution it breaks down instantly:

Na₂CO₃·1.5H₂O₂ → Na₂CO₃ + 1.5 H₂O₂

The active oxygen content of technical-grade sodium percarbonate is approximately 13–14% by weight, equivalent to roughly 30% aqueous H₂O₂. This makes it attractive as a dry, shelf-stable peroxide source for whitening formulations.

Originally developed for household oxygen bleaches and laundry products, sodium percarbonate entered dentistry as an alternative to sodium perborate — a compound with a higher cytotoxicity profile. In the early 2000s it appeared in overnight whitening film products (e.g., Crest Night Effects).

How It Works

Dissolved in saliva, sodium percarbonate releases H₂O₂. The hydrogen peroxide molecule (molecular weight 34 g/mol) is small and hydrophilic, allowing it to diffuse through enamel and into dentin without surface accumulation.

Inside the mineralised tissue, H₂O₂ generates free radicals — primarily hydroxyl radicals (OH•) — through Fenton-type reactions with trace metal ions. These radicals attack chromogenic organic molecules that absorb visible light: they cleave poly-conjugated double bonds in compounds like porphyrins, tannins, and carotenoids. The resulting short-chain fragments no longer absorb visible wavelengths. The tooth appears lighter.

Sodium carbonate, the other breakdown product, creates a mildly alkaline environment (pH 10–11 in concentrated solution). This accelerates H₂O₂ decomposition and enhances radical generation. It may also partially buffer acidic salivary conditions during the procedure, reducing the risk of erosion compared to acid-based whitening systems.

One key distinction from carbamide peroxide: sodium percarbonate releases H₂O₂ rapidly — within minutes — rather than over 4–8 hours. This produces a sharp, short concentration peak rather than a prolonged low-level exposure.

Clinical Evidence

Whitening films. Li et al. (2004) conducted a randomised, double-blind, placebo-controlled trial with 50 adults. A 19% sodium percarbonate gel (Crest Night Effects) was brush-applied nightly and rinsed off in the morning. After 2 weeks the percarbonate group showed significantly greater reduction in yellowness (Δb*) versus placebo, with cumulative improvement over 6 weeks. Whitening partially persisted 4 weeks after treatment ended (PMID 15055982).

A follow-up long-term stability trial by the same group (Li et al., 2009) compared 6% H₂O₂ strips (Crest Whitestrips) against 19% percarbonate film. End-of-treatment Δb* was −2.37 (strips) vs −1.36 (film). Both returned gradually toward baseline over 18 months post-treatment (PMID 19681255). Conclusion: percarbonate film works but underperforms H₂O₂ strips at equivalent application time.

Intracoronal bleaching. Pereirinha et al. (2001) tested sodium percarbonate mixed with distilled water (no added H₂O₂) on artificially stained extracted teeth. The percarbonate-only preparation produced significant lightening, demonstrating that its intrinsic peroxide content is sufficient for clinically meaningful bleaching without additional H₂O₂ (PMID 11194360).

Limitations. Neither sodium percarbonate nor any other peroxide removes deep tetracycline staining or fluorosis effectively within typical treatment windows. Short contact time (as in a 2-minute brushing) is insufficient for meaningful bleaching — effective use requires extended exposure (≥30 minutes). This is why it does not function as a primary whitening agent in conventional toothpaste.

Safety

Cytotoxicity and genotoxicity. Tunc et al. (2010) evaluated H₂O₂, carbamide peroxide, sodium perborate, and sodium percarbonate against 3T3/NIH mouse fibroblasts (MTT assay, 24-hour exposure). All agents showed dose-dependent cytotoxicity. Sodium percarbonate and H₂O₂ were significantly more cytotoxic than sodium perborate. In micronucleus genotoxicity assays, sodium percarbonate showed an intermediate frequency versus controls — less than H₂O₂, comparable to sodium perborate. The authors concluded that in vivo safety confirmation is needed before widespread clinical use (PMID 20078698).

Cervical root resorption risk. Lim et al. (2018) examined extraradicular peroxide diffusion from sodium percarbonate in an intracoronal bleaching model (60 single-rooted premolars). Sodium percarbonate penetrated cervical periodontal tissues via dentinal tubules. This diffusion is the hypothesised trigger for invasive cervical resorption when bleaching agents are used without a proper intraorifice barrier (PMID 30388301).

Regulatory status. Under EU Regulation (EC) 1223/2009, products releasing more than 0.1% H₂O₂ are restricted: concentrations up to 6% H₂O₂ equivalent require professional dental administration; consumer products are limited to ≤0.1% H₂O₂ equivalent with mandatory labelling. Since sodium percarbonate is effective at concentrations that yield well above 0.1% H₂O₂, most clinically relevant concentrations are legally restricted for OTC retail in the EU. The FDA regulates sodium percarbonate in oral care through its calculated H₂O₂ equivalent, with no separate standalone limit.

Critical gap. All available clinical trials cover 2–6 week treatment periods. There are no published long-term data on daily chronic use in toothpaste — months or years of twice-daily exposure — and its cumulative effect on pulp tissue and dentin.

QDRO Position

QDRO does not include sodium percarbonate in current v.daily or v.pro formulas for two reasons.

First, there are no long-term safety data for chronic daily use in a rinse-off toothpaste format. All clinical evidence comes from extended-contact applications (films, intracoronal pastes) — not from a 2-minute brushing model where bioavailability and cumulative pulp exposure are different and unstudied.

Second, the fast H₂O₂ release profile creates a brief high-concentration oxidative spike without therapeutic benefit at typical toothpaste contact time. That is risk without upside.

Where whitening is the goal, QDRO prefers approaches with a better-characterised safety profile: hydrated silica as a mild polishing abrasive and xylitol to inhibit chromogenic bacteria. Sodium percarbonate remains on the watch list — if long-term toothpaste-format data emerge, the assessment will be revisited.

---

Sources:

• Li Y et al. (2004). Placebo-controlled clinical trial of a 19% sodium percarbonate whitening film. J Clin Dent. PMID: 15055982
• Li Y et al. (2009). Clinical trial of long-term color stability of hydrogen peroxide strips and sodium percarbonate film. J Clin Dent. PMID: 19681255
• Pereirinha NM et al. (2001). Bleaching effect of sodium percarbonate on discolored pulpless teeth in vitro. J Endod. PMID: 11194360
• Tunc ES et al. (2010). Cytotoxicity and genotoxicity of sodium percarbonate: a comparison with bleaching agents commonly used in discoloured pulpless teeth. Int Endod J. PMID: 20078698
• Lim MY et al. (2018). Sodium percarbonate as a novel intracoronal bleaching agent: assessment of the associated risk of cervical root resorption. Int Endod J. PMID: 30388301